Skip to navigation Skip to content

Fabry disease (FD) Program in Pharmaceutical Benefits Scheme (PBS) 012-24080524

Expand/Collapse all sectionsExpand all


This document outlines details of PBS-subsidised migalastat for patients with Fabry disease (FD).

FD and listing dates

FD is a rare genetic disorder where the deficiency or absence of an enzyme that breaks down a certain type of fat results in a build up of that fat in many parts of the body and causes a range of symptoms.

Listing date: migalastat - 1 September 2024.

See Written Authority Required Drugs for more details.

Enquiries

Transfer enquiries about prescription arrangements to PBS Complex Drugs Programs and choose the option relevant to the condition treated.

The Resources page contains:

  • application forms
  • contact details
  • restriction and item codes
  • the PBS schedule
  • Services Australia website link

Online Pharmaceutical Benefits Scheme (PBS) Authorities System (OPA System)

Processing an existing Authority request in the Pharmaceutical Benefits Scheme (PBS)

Processing and National Demand Allocation (PaNDA)

Processing Complex Authority Required Listings

Written Authority Required Drugs

Processing Delayed Assessment requests in the Pharmaceutical Benefits Scheme (PBS)

Processing new Authority requests in the Pharmaceutical Benefits Scheme (PBS)